Your Article Summary
See Latest ArticlesCoffee consumption and risk of lung cancer: A meta-analysis
Lung Cancer, 05/13/09
Tang N et al. - To clarify the role of coffee in lung cancer, it was reported that high or an increased consumption of coffee may increase the risk of lung cancer. Because the residual confounding effects of smoking or other factors may still exist, these results should be interpreted with caution.
Methods- PubMed and EMBASE databases were searched (from 1966 to January 2009) and the reference lists of retrieved articles.
- Study-specific risk estimates were pooled using random-effects model.
- 5 prospective studies and 8 case–control studies involving 5347 lung cancer cases and 104,911 non-cases were included.
- Combined results indicated a significant positive association between highest coffee intake and lung cancer.
- An increase in coffee consumption of 2 cups/day was associated with a 14% increased risk of developing lung cancer.
- In stratified analyses, highest coffee consumption was significantly associated with increased risk of lung cancer in prospective studies, but borderline significantly associated with decreased risk of lung cancer in non-smokers.
- Decaffeinated coffee drinking was associated with decreased lung cancer risk, although the number of studies on this topic was relatively small.
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 73%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 72%
Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Cancer Research, 10/06/09
Relevance Score: 71%
Noninvasive detection of lung cancer by analysis of exhaled breath
BMC Cancer, 10/09/09
Relevance Score: 70%
African American lung cancer patients may have different response to new cancer-fighting drugs
EurekAlert, 10/08/09
Relevance Score: 70%
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy
Anti-Cancer Drugs, 12/09/09
Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/09/09
Beta-Tubulin III mRNA expression and docetaxel sensitivity in non-small cell lung cancer
Clinical and Investigative Medicine, 12/09/09